Compare Altair Therapeutics vs gera Therapeutics
Customers evaluate the quality of Altair Therapeutics's products using the following success metrics.
Overview
Altair Therapeutics is 17 yrs old and is based in United States.
Altair Therapeutics is a biotechnology company focused on the discovery, development and commercialization of antisense drugs for respiratory conditions.
gera Therapeutics is 24 yrs old and is based in Canada.
Aegera Therapeutics, located in Montreal, Canada, is a business unit of Pharmascience focused on developing targeted therapeutics to address major unmet medical needs. Aegera focuses on preclinical and early-stage clinical development through integration of "in-house" medicinal chemistry, biochemistry, cell biology, pharmacokinetics and in vivo pharmacology/efficacy. Aegera has two oncology programs in clinical development. Aegera is also dedicated to identifying novel development candidates based upon its core technologies, internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
Demo Video
Leadership
Paul Brennan (Chief Executive Officer, President)
Michael J Berendt (Chief Executive Officer, President)
Investors
Ionis Pharmaceuticals, Forward Ventures
Pharmascience, GrowthWorks
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Altair Therapeutics has not claimed their profile.
Work for Altair Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Altair Therapeutics?
Claim your profile now.
Information not available because gera Therapeutics has not claimed their profile.
Work for gera Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for gera Therapeutics?
Claim your profile now.